IV Vitamin C: Help for Cancer, Learn More

IV Vitamin C and Cancer Seminar Scheduled for October -

Dear Friends and Co-Learners,

We would like to invite you to our "Second Annual Riordan IVC and Cancer Symposium", Oct 8-9, 2010.

This year's Riordan Intravenous Vitamin C (IVC) and Cancer Symposium offers something unique. Beyond focusing on IVC therapy itself, we will take a collective look at how Intravenous Vitamin C has inspired our cancer patients to live a better life.

Quality of life is the ultimate goal of any medical treatment worth its salt. Modern degenerative illnesses often have their genesis in decades of poor lifestyle choices, toxic exposures, high stress and non-whole food diets. The universal underlying mechanism for the resultant diseases is simply uncontrolled systemic inflammation. Cancer is no exception.

In order to turn cancer around and restore our patient's quality of life, they will need to choose a better way of life. Intravenous Vitamin C is a beginning point, not an end of itself. It is a fire hose to put out the raging fire, but it is no substitute for the lifestyle changes our cancer patients will need to adopt in order to sustain their health improvements.

The choice for an anticancer lifestyle is initiated and facilitated by the hope that is spawned from the radical benefits that an intensive IVC/ nutritional intervention can offer. Our 2nd Annual Riordan IVC Symposium will focus on this renewed quality of life that IVC therapy patients experience...an experience that often leads them to refocus their life choices on a new and better way of living.

It is a journey from despair to hope...from neglect to better self care...from disease to health. Please join us as we explore this crucial (but too often neglected) phase of the recovery from cancer.

For more information about the Symposium or to register, please call1-800-447-7276 or visit: http://www.riordanclinic.org/symposium.shtml

Sincerely,

Ron Hunninghake, MD 

Chief Medical Officer

Riordan Clinic
33100 N. Hillside Ave. - Wichita, KS 67219 - (316) 682-3100

Some of the 30+ vitamin C posts on Natural Health News

Natural Health News: High Dose Vitamin C : SAFE

Jul 20, 2010

In a study designed to assess the use and safety of high-dose intravenous (IV) vitamin C administration by complementary and alternative medicine (CAM) practitioners, the authors found that a) high-dose IV vitamin C is widely used by ...

Enjoy Your Holiday, GMO FREE

Jul 01, 2010

Vitamin A - Through its concentration of beta-carotene, Watermelon supplies a rich source of Vitamin A, another cancer fighting anti-oxidant along with Lycopene and Vitamin C. A cup of Watermelon supplies your body with over 10% of its ...

Natural Health News: Vitamin C Facts

Jul 24, 2009

I recently cured myself and my wife using that "miracle drug" vitamin C, and I posted an article "What Doctors Don't Know". This article is scheduled to appear in the Holistic Health Magazine in September. It is reprinted below. ...

Natural Health News: Vitamin C or Tamiflu, which would you choose

Aug 08, 2009

Patrick Holford notes that in his June 2005 newsletter he interviewed Dr Thomas Levy, who has provided the definitive proof in his book ' Vitamin C, Infectious Diseases and Toxins: Curing the Incurable'. ...

http://naturalhealthnews.blogspot.com/

High Dose Vitamin C : SAFE

"Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects," Padayatty SJ, Sun AY, et al, PLoS One, 2010; 5(7): e11414. (Address: Molecular and Clinical Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, United States of America).

In a study designed to assess the use and safety of high-dose intravenous (IV) vitamin C administration by complementary and alternative medicine (CAM) practitioners, the authors found that a) high-dose IV vitamin C is widely used by CAM practitioners, most commonly in the treatment of patients with infection, cancer, or fatigue; and b) aside from already known complications of IV vitamin C in patients with renal impairment or glucose 6 phosphate dehydrogenase deficiency, high-dose IV vitamin C use was found to be "remarkably safe." Of 199 practitioners who responded to a survey, 172 administered IV vitamin C to their patients, totaling 11,233 in the year 2006 and 8,876 in the year 2008. On average, the dose administered was 28 grams every 4 days, with a total of 22 treatments per patient. Data from 9,328 patients was available, and of these patients, 101 were found to have mostly minor side effects including lethargy/fatigue in 59 patients, change in mental sta tus in 21 patients, and vein irritation/phlebitis in 6 patients. Regarding serious adverse events, the authors found that there had been 2 deaths, both in patients known to be at risk for IV vitamin C. The authors conclude, "Physicians should inquire about IV vitamin C use in patients with cancer, chronic, untreatable, or intractable conditions and be observant of unexpected harm, drug interactions, or benefit."

Reference these and other vitamin C related posts from Natural Health News -

http://naturalhealthnews.blogspot.com/2009/12/vitamin-c-and-healing-disease.html
http://naturalhealthnews.blogspot.com/2009/06/vitamin-c-facts.html
http://naturalhealthnews.blogspot.com/2006/10/dr-levy-on-vitamin-c.html
http://naturalhealthnews.blogspot.com/2010/01/iv-vitamin-c-saves-man-with-flu-damaged.htmlhttp://naturalhealthnews.blogspot.com/2009/03/vitamin-c-cancer-study-challenged.html
http://naturalhealthnews.blogspot.com/2008/11/vitamin-c-effective-in-reducing.html

IV Vitamin C Saves Man with Flu Damaged Lungs

If only US medicine was this open minded!

After 20 days of life-sustaining ECMO treatment and other critical care, the patient, who was unconscious by induced coma, had not responded. The ICU team advised the family of the likely outcome and had prepared them for the possibility of the patient’s death.
Family members approached Centre for Advanced Medicine Limited (CAM) for advice on the clinical use of intravenous vitamin C for such cases.
At the family’s request, information was provided to ICU doctors including ISO 9001:2008 registered protocols, safety data, dosages and access to vials of IV vitamin C under CAM’s license for wholesale medicines.
The ICU team agreed to administer intravenous vitamin C according to the family’s wishes. This decision acknowledged the family’s rights, in compliance with the New Zealand Health and Disability Act, 1997.
The patient received intravenous vitamin C starting on the evening of 21 July, continuing until 29 July. 25 grams was provided on the first day increasing over the first three days to 50 grams twice daily which was sustained for a further six days.
By 24 July x-rays indicated increasing lung function and ECMO external oxygenation was discontinued on 26 July. After several days of assisted ventilation and critical care for ongoing secondary conditions, the patient was able to commence his recovery and rehabilitation.

Read more about the benefits of Vitamin C by searching Natural Health News.